“BETTER OUTCOME OF HIGH-DOSE CEFTAZIDIME IN HEMATO – ONCOLOGICAL PATIENTS WITH INFECTIONS CAUSED BY EXTENSIVELY DRUG-RESISTANT PSEUDOMONAS AERUGINOSA” (2022) Mediterranean Journal of Hematology and Infectious Diseases, 15(1), p. e2023001. doi:10.4084/MJHID.2023.001.